课题基金 / 基金详情

EFFICACY OF SPINAL KETOROLAC TO REDUCE EXPERIMENTAL PAIN

EFFICACY OF SPINAL KETOROLAC TO REDUCE EXPERIMENTAL PAIN
脊髓酮咯酸减轻实验性疼痛的功效
批准号:
7376700
负责人:
James Eisenach
金额:
$2.28万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-04-17 至 2007-02-28
关键词:

项目摘要

项目成果

James Eisenach的其他基金

相似基金

相关文献

中文摘要
翻译
本子项目是利用由NIH/NCRR资助的中心赠款提供的资源的众多研究子项目之一。子项目和研究者(PI)可能已经从另一个NIH来源获得了主要资金,因此可以在其他CRISP条目中表示。列出的机构是中心的,不一定是研究者的机构。之所以进行这项研究,是因为疼痛对于有各种医疗问题的患者以及手术或创伤后的患者来说是一个重要的问题。目前可用的止痛药可能不能缓解所有类型的疼痛,或者可能只是在产生副作用和潜在并发症的剂量下缓解疼痛。本研究中的药物可能对更好地治疗疼痛有一定作用。本研究的目的是观察一定剂量的酮罗拉酸(非麻醉性止痛药),脊柱注射(注射到脊柱附近背部的液体中)是否对暴露在少量UV-B辐射(轻度晒伤)下的小区域皮肤疼痛或不适有任何影响。正在研究的药物是FDA批准的药物;然而,我们正在IND 62179下进行这项研究,因为我们正在通过与指示不同的途径给药。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This research study is being done because pain is a significant problem for patients with a variety of medical problems and following surgery or traumatic injury. Currently available pain medications may not relieve all types of pain or may relieve pain only at doses that produce side effects and potential complications. The medication in this study may have a role in better treatment of pain. The goals of this study are to see if a dose of ketorolac (non-narcotic pain reliever), given spinally (given into the fluid in the back near the spine) has any effect on pain or discomfort from a small area of skin that we will expose to a small amount of UV-B radiation (a mild sunburn). The medication being studied is an FDA approved medication; however, we are conducting this study under IND 62,179 because we are administering the medication by a different route than it is indicated for.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Oxytocin: a pain disease-modifying agent in the nervous system after injury
Creating PK/PD models for oxytocin action in humans and bridging to intranasal delivery
Creating PK/PD models for oxytocin action in humans and bridging to intranasal delivery
Oxytocin: a pain disease-modifying agent in the nervous system after injury
海外基金